Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Keith, I agree with your comments that Dan was likely pushed out because of investor unrest regarding his lack of value creation and continuing cycle of dilution without any value-added deal making. With the exception of the Amgen deal, all other deals and collaborations he did were without a clear focus/strategy and weak financially. His only strength was his salesmanship in pitching investors to go in on his numerous dilutive offerings. His strength was also his weakness, because he lacked honesty or character and his efforts of tricking shareholders, putting his own financial interests ahead and using the annual proxy process as his own personal piggy bank finally caught up with him. I firmly believe the silence is leading up to a major BP deal or outright sale. Investors have already put their foot down regarding continuing the ongoing dilution cycle with no value added by giving Dan the boot. I'm optimistic the silence will end in a favorable outcome for investors. Otherwise, I'm sure Adage would have sold everything already if they got the impression shareholders will get diluted again on unfavorable terms.